The President's Cancer Panel urges improvements in value frameworks and expanded insurance coverage as ways to better align prices with value and enhance the affordability of cancer drugs in a report released March 13.
Entitled "Promoting Value, Affordability and Innovation in Cancer Drug Treatment," the report offers six recommendations that align with biopharma industry...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?